19-17872266-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000453.3(SLC5A5):c.-54C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00356 in 1,304,458 control chromosomes in the GnomAD database, including 128 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.017 ( 76 hom., cov: 32)
Exomes 𝑓: 0.0018 ( 52 hom. )
Consequence
SLC5A5
NM_000453.3 5_prime_UTR
NM_000453.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.25
Genes affected
SLC5A5 (HGNC:11040): (solute carrier family 5 member 5) This gene encodes a member of the sodium glucose cotransporter family. The encoded protein is responsible for the uptake of iodine in tissues such as the thyroid and lactating breast tissue. The iodine taken up by the thyroid is incorporated into the metabolic regulators triiodothyronine (T3) and tetraiodothyronine (T4). Mutations in this gene are associated with thyroid dyshormonogenesis 1.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 19-17872266-C-T is Benign according to our data. Variant chr19-17872266-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 803544.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0551 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A5 | NM_000453.3 | c.-54C>T | 5_prime_UTR_variant | 1/15 | ENST00000222248.4 | NP_000444.1 | ||
SLC5A5 | XM_011528192.3 | c.-54C>T | 5_prime_UTR_variant | 1/15 | XP_011526494.1 | |||
SLC5A5 | XM_011528193.4 | c.-52+223C>T | intron_variant | XP_011526495.1 | ||||
SLC5A5 | XM_017027158.2 | c.-52+223C>T | intron_variant | XP_016882647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A5 | ENST00000222248.4 | c.-54C>T | 5_prime_UTR_variant | 1/15 | 1 | NM_000453.3 | ENSP00000222248 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0166 AC: 2518AN: 152018Hom.: 76 Cov.: 32
GnomAD3 genomes
AF:
AC:
2518
AN:
152018
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00183 AC: 2111AN: 1152326Hom.: 52 Cov.: 16 AF XY: 0.00155 AC XY: 896AN XY: 579120
GnomAD4 exome
AF:
AC:
2111
AN:
1152326
Hom.:
Cov.:
16
AF XY:
AC XY:
896
AN XY:
579120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0166 AC: 2529AN: 152132Hom.: 76 Cov.: 32 AF XY: 0.0163 AC XY: 1216AN XY: 74388
GnomAD4 genome
AF:
AC:
2529
AN:
152132
Hom.:
Cov.:
32
AF XY:
AC XY:
1216
AN XY:
74388
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
15
AN:
3476
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Thyroid dyshormonogenesis 1 Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | Aug 22, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 27, 2021 | This variant is associated with the following publications: (PMID: 21565787) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at